COVID guidelines update and Antifungal prophylaxis guidelines

The MUHC ASP committee is happy to announce the update and publication of several guidelines:

Pre-exposure prophylaxis to COVID : Recommended Evusheld dose is now increased to 300/300 mg
COVID management guidelines (minor changes)
COVID outpatient decision tree : inclusion of situation in which to give Evusheld
Antifungal prophylaxis guidelines (developed with the help of Transplant and Hematology-oncology team)

We are also proud to publish our Annual report for 2021-2022. It is now available in the section Resources of the website.

Good reading to all and happy thanksgiving!

Francois Bourdeau, ASP co-chair

Recent Posts

See All

Correction in Antifungal prophylaxis for high-risk (immunocompromised)

Correction made for Heart transplant and Lung transplant recipients: both anti-mold AND anti-PJP prophylaxis recommended.

NEW UPDATE: *Change in process for outpatient COVID-19 management*

To MUHC users: Please note that as of Dec 5, 2022, requests for outpatient antiviral management of COVID-19 for HIGH RISK patients should be directed to the ID-AMB (formerly MicroB/Lachine) service ra

UTI Guidelines Update for the St-Jean!

The ASP group is happy to announce the update to the MUHC UTI guidelines! It includes updated MUHC urine culture antibiogram, most frequent uropathogens at our institution, new recommendations for emp